Public Title Status Last Date Modified
Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease (MOSAIC) . . . Terminated 30 Jan 2020
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC-3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia . . . Completed 13 Jun 2018
A Phase III/IV, Stratified, Randomized, Observer Blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of a Cell-Based Quadrivalent Subunit Influenza Virus Vaccine Comp . . . Completed 13 Feb 2020
A Phase III, Observer-Blind, Randomized, Non-influenza Vaccine Comparator-Controlled, Parallel-Group, Multi-Country Study in Children Aged 6-35 Months to Assess the Safety and Efficacy of Abbott’s C . . . Completed 26 Aug 2020
MB02-C-02-17 - STELLA-A Randomized, Multicenter, Multinational, Double­Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With . . . Ongoing 06 Feb 2018
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Particip . . . Completed 04 Oct 2018
A multicenter, open-label, sponsor-blinded, randomized, active-controlled, parallel group, pivotal study to evaluate the efficacy, safety, and tolerability of murepavadin given with ertapenem versus a . . . Terminated 03 Oct 2019
Open-label, uncontrolled, multicenter, Phase IV study including 120 subjects distributed into 2 groups: 60 subjects aged 18 to 60 years and 60 subjects aged 61 years or older . . . Completed 05 May 2016
Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection . . . Terminated 30 Jun 2020
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Asthmatic Adults and Adolescents Inadequately Controll . . . Completed 17 May 2017
A Phase 3 Randomized, Double-Blind Study Of Pf 06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin For The First-Line Treatment Of Patients With Advanced Non-Squamous Non- . . . Completed 22 Apr 2019
Cetaphil Restoderm Effect on young children with Atopic Dermatitis - CREATE  Completed 17 Jan 2017
Confirmatory Study of DSP-5423P in Patients with Schizophrenia (Phase 3) Completed 24 Jul 2019
AURORA (AURinia Orelvo Renal Asseements) 1 : Aurinia Renal Response in Active Lupus with Voclosporin . . . Ongoing 05 Sep 2017
A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncon . . . Ongoing 15 Feb 2018
A randomized, partially-blinded, active-controlled multicenter study of secukinumab to demonstrate reduction of radiographic progression versus GP2017 (adalimumab biosimilar) at 104 weeks and to asses . . . Ongoing 12 Aug 2020
A 12-week double-blind, randomized, multi-center study comparing the efficacy and safety of once monthly subcutaneous AMG 334 against placebo in adult episodic migraine patients (EMPOwER) . . . Completed 23 Apr 2020
Study of S-033188 Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications (CAPSTONE 2) . . . Completed 28 May 2018
Efficacy and Safety of MYL-1402O Compared With Avastin in the First-line Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer . . . Pending 27 Jan 2017
A two-year, phase III randomized, double-blind, parallel-group, placebo-controlled trial to evaluate the safety, efficacy, and tolerability of 300 mg s.c. secukinumab versus placebo, in combination wi . . . Pending 02 Sep 2020
Efficacy of Mandibular Advancement Device in the Treatment of Obstructive Sleep Apnea Syndrome among Filipinos Seen in a DOH Tertiary Hospital: A Pilot Study . . . Ongoing 14 Apr 2016
"A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Sitagliptin in Pediatric Patients With Type 2 Diabetes Mellitus With Inade . . . Completed 24 Aug 2020
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic) . . . Terminated 27 Aug 2020
A RANDOMIZED OPEN LABEL PHASE 2B/3 STUDY OF THE SAFETY AND EFFICACY OF NP-120 (IFENPRODIL) FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH CONFIRMED COVID 19 DISEASE . . . Ongoing 12 Aug 2020
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium to High-dose Inhaled Corticosteroid Plus Long- . . . Ongoing 29 Jun 2020

Copyright © One Window Project 2020. All rights reserved.